CD8A and gastric cancer: However, numerous cycles of chemotherapy may lead to a reduction in the immune functions of the patients with gastric cancer, with decreased ratios of CD4+ and CD4+/CD8+ cells, reduced NK cell activities and an increased proportion of CD8+ cells (8).